Wed, July 12, 2017
Tue, July 11, 2017
Mon, July 10, 2017
Fri, July 7, 2017
Thu, July 6, 2017
Wed, July 5, 2017
Mon, July 3, 2017

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $103 on, Jul 10th, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-103-on-jul-10th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $105 to $103 on, Jul 10th, 2017.

Matthew has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Dane Leone of "BTIG" Downgraded from Strong Buy to Hold on, Friday, June 30th, 2017


This is the rating of the analyst that currently disagrees with Matthew


  • Matthew Luchini of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $108 on, Tuesday, June 6th, 2017